Skip to main content
. Author manuscript; available in PMC: 2020 Mar 3.
Published in final edited form as: ACS Nano. 2019 Oct 11;13(10):11034–11048. doi: 10.1021/acsnano.9b02807

Figure 1.

Figure 1.

(A) FcRn binds to Fc-Ivermectin-NPs in an acidic environment, NPs transcytose across the epithelial-cell barrier and get release at physiological pH of blood. (B) Synthetic strategy of PLGA-b-PEG-Mal. (C) GPC traces of the polymers. (D) Synthesis of IVM loaded NPs using nanoprecipitation. (E) Incorporation of targeting antibody Fc on the NPs.